WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) issued the following statement from President and CEO Scott Whitaker on President Trump’s signing of legislation to repeal the medical device excise…

WASHINGTON, D.C. – AdvaMed® President and CEO Scott Whitaker and AdvaMedDx® Executive Director Susan Van Meter issued the following statements upon congressional passage of the Laboratory Access for Beneficiaries (LAB) Act as part of the…

Contact: Mark [email protected] WASHINGTON, D.C. – AdvaMed® President and CEO Scott Whitaker today released the following statement on Senate passage of full repeal of the medical device excise tax: “On behalf…

WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) issued the following statement from President and CEO Scott Whitaker on the U.S. House of Representatives’ vote to repeal the medical device…

WASHINGTON, D.C. – AdvaMed® President and CEO Scott Whitaker released the following statement on the announcement by congressional leadership of a funding agreement that includes full repeal of the medical…

WASHINGTON, D.C. – In an op-ed published today in Morning Consult, AdvaMed® President and CEO Scott Whitaker urges Congress to act before the medical device excise tax comes back into effect Jan. 1.

WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) issued the following statement today from President and CEO Scott Whitaker regarding the U.S. Senate’s confirmation of Dr. Stephen Hahn to…

WASHINGTON, D.C. – In today’s Wall Street Journal, the editorial board wrote that Congress “should stop a return of the destructive” medical device excise tax scheduled to go into effect on Jan.…